Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan

Area of Science:

• Pharmacology
• Cardiology
• Epidemiology

Background:

• Limited empirical data exists on the association between antidepressant use and valvular heart disease (VHD).
• Understanding this relationship is crucial for patient safety and clinical practice.

Purpose of the Study:

• To investigate the association between antidepressant use and the risk of developing valvular heart disease (VHD).
• To explore how timing, duration, dose, and type of antidepressants influence VHD risk.

Main Methods:

• A nested case-control study was conducted using Taiwan's National Health Insurance Research database.
• 874 patients with VHD (cases) and 3496 matched controls were identified from a cohort using at least 3 prescription antidepressants.
• Conditional logistic regression models analyzed the association between antidepressant use patterns and VHD risk.

Main Results:

• Current antidepressant use was associated with a 1.4-fold increased risk of VHD (aOR 1.44; 95% CI 1.17-1.77).
• A dose-response relationship was observed for cumulative duration and dose of antidepressants.
• Current users of tricyclic antidepressants showed a significantly higher risk of VHD (aOR 1.40; 95% CI 1.05-1.87).

Conclusions:

• Antidepressant use is associated with an elevated risk of valvular heart disease (VHD).
• The risk of VHD varies depending on the specific type of antidepressant used.